Lakos, Gabriella <br/><br/>
Targeted disruption of TGF-beta/Smad3 signaling modulates skin fibrosis in a mouse model of scleroderma.  [electronic resource] 

 -  The American journal of pathology  Jul 2004 
 - 203-17 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0002-9440 
<br/><br/><label>Standard No.: </label>10.1016/s0002-9440(10)63289-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Actins--biosynthesis<br/>Animals<br/>Bleomycin--pharmacology<br/>Blotting, Western<br/>Cells, Cultured<br/>Collagen--biosynthesis<br/>Connective Tissue Growth Factor<br/>Disease Models, Animal<br/>Fibroblasts--drug effects<br/>Fibronectins--biosynthesis<br/>Fibrosis--chemically induced<br/>Flow Cytometry<br/>Gene Expression Regulation--drug effects<br/>Gene Targeting<br/>Hydroxyproline--analysis<br/>Immediate-Early Proteins--drug effects<br/>Immunohistochemistry<br/>In Situ Hybridization<br/>Intercellular Signaling Peptides and Proteins--metabolism<br/>Mice<br/>Mice, Knockout<br/>Scleroderma, Systemic--metabolism<br/>Signal Transduction--drug effects<br/>Skin--chemistry<br/>Trans-Activators--genetics<br/>Transforming Growth Factor beta--genetics